John A. Ward

Array ( [id] => 7288629 [patent_doc_number] => 20040109851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Use of immature dendritic cells to silence antigen specific cd8cell function' [patent_app_type] => new [patent_app_number] => 10/451039 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10645 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20040109851.pdf [firstpage_image] =>[orig_patent_app_number] => 10451039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674669 [patent_doc_number] => 20040127449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Method of inducing vasodilation and treating pulmonary hypertension using adenoviral -mediated transfer of the nitric oxide synthase gene' [patent_app_type] => new [patent_app_number] => 10/740844 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8607 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127449.pdf [firstpage_image] =>[orig_patent_app_number] => 10740844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957894 [patent_doc_number] => 20050214264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Sacromastigophoric therapeutic agent delivery system' [patent_app_type] => utility [patent_app_number] => 10/735203 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9717 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214264.pdf [firstpage_image] =>[orig_patent_app_number] => 10735203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7477432 [patent_doc_number] => 20040123336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Method of modulating neutralizing antibodies formation in mammals, and uses thereof in gene therapy, animal transgenesis and in functional inactivation of endogenous proteins' [patent_app_type] => new [patent_app_number] => 10/727172 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12462 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20040123336.pdf [firstpage_image] =>[orig_patent_app_number] => 10727172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305966 [patent_doc_number] => 20040116372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Therapy for cellular accumulation in chronic inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/716647 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15518 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116372.pdf [firstpage_image] =>[orig_patent_app_number] => 10716647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122434 [patent_doc_number] => 20050014263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Materials and methods for delivery and expression of heterologous DNA in vertebrate cells' [patent_app_type] => utility [patent_app_number] => 10/706635 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31060 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014263.pdf [firstpage_image] =>[orig_patent_app_number] => 10706635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307472 [patent_doc_number] => 20040141982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Use of genetically engineered antibodies to treat multiple myeloma' [patent_app_type] => new [patent_app_number] => 10/704206 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13548 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141982.pdf [firstpage_image] =>[orig_patent_app_number] => 10704206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 437392 [patent_doc_number] => RE039788 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-08-21 [patent_title] => 'Gene therapy' [patent_app_type] => reissue [patent_app_number] => 10/701022 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9685 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039788.pdf [firstpage_image] =>[orig_patent_app_number] => 10701022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5696272 [patent_doc_number] => 20060156419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Mouse model for autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 10/532971 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15993 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20060156419.pdf [firstpage_image] =>[orig_patent_app_number] => 10532971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5684601 [patent_doc_number] => 20060200871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Transgenic non-human animals with expanded mature b cell and plasma cell populations' [patent_app_type] => utility [patent_app_number] => 10/532040 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6719 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20060200871.pdf [firstpage_image] =>[orig_patent_app_number] => 10532040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675754 [patent_doc_number] => 20040126364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Treatment for bone disorders' [patent_app_type] => new [patent_app_number] => 10/683516 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7195 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126364.pdf [firstpage_image] =>[orig_patent_app_number] => 10683516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425239 [patent_doc_number] => 20040161409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Induction of immune response to antigens expressed by recombinant adeno-associated virus' [patent_app_type] => new [patent_app_number] => 10/679875 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21660 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161409.pdf [firstpage_image] =>[orig_patent_app_number] => 10679875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704807 [patent_doc_number] => 20060193855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 10/527931 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 28064 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193855.pdf [firstpage_image] =>[orig_patent_app_number] => 10527931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463730 [patent_doc_number] => 20040101522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivo' [patent_app_type] => new [patent_app_number] => 10/660369 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17494 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101522.pdf [firstpage_image] =>[orig_patent_app_number] => 10660369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211871 [patent_doc_number] => 20050054055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Human antibodies derived from immunized xenomice' [patent_app_type] => utility [patent_app_number] => 10/658521 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12657 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054055.pdf [firstpage_image] =>[orig_patent_app_number] => 10658521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382626 [patent_doc_number] => 20040082032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Cctra gene as a tool to produce male-only progeny in the mediterranean fruitfly ceratitis capitata' [patent_app_type] => new [patent_app_number] => 10/471211 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8953 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082032.pdf [firstpage_image] =>[orig_patent_app_number] => 10471211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7036706 [patent_doc_number] => 20050034175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Immune cloning and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/654724 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2166 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20050034175.pdf [firstpage_image] =>[orig_patent_app_number] => 10654724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590911 [patent_doc_number] => 20060040363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Human antibodies derived from immunized xenomice' [patent_app_type] => utility [patent_app_number] => 10/656623 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8816 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040363.pdf [firstpage_image] =>[orig_patent_app_number] => 10656623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425444 [patent_doc_number] => 20040161433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Method for in vitro culture of lymphocytes and composition for use in immune therapy' [patent_app_type] => new [patent_app_number] => 10/646743 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6924 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161433.pdf [firstpage_image] =>[orig_patent_app_number] => 10646743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849193 [patent_doc_number] => 07381711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Substances for preventing and treating autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 10/523655 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3967 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381711.pdf [firstpage_image] =>[orig_patent_app_number] => 10523655 [rel_patent_id] =>[rel_patent_doc_number] =>)